Zahid Balouch, Fahmida Khatoon
자료유형 | 단행본 |
---|---|
개인저자 | Zahid Balouch, Fahmida Khatoon.,editor. |
단체저자명 | SpringerLink (Online service). |
서명/저자사항 | Therapeutic Proteins Against Human Diseases [electronic resource] / edited by Fahmida Khatoon Zahid Balouch. |
판사항 | 1st ed. 2022. |
형태사항 | IX, 173 p. 1 illus:online resource. |
기본자료 저록 | Springer Nature eBook |
기타형태 저록 | Printed edition:9789811678967Printed edition:9789811678981Printed edition:9789811678998 |
ISBN | 9789811678974 |
기타표준부호 | 10.1007/978-981-16-7897-4 |
내용주기 | Proteins drug targeting and its therapeutics -- Interferons -- Epidermal growth factor (egf) in wound repair -- Therapeutic protein against autoimmune disorders: Intracellular and extracellular properties -- Prions as Therapeutic proteins and their Prospect as Drug Delivery Agent -- INTERLEUKIN - 2 -- Bioinformatics resources, tools, and strategies in designing therapeutic proteins -- Therapeutic proteins used in human pancreatic disease -- Therapeutic role of soybean-derived lunasin peptide in colon cancer treatment: A recent updates from literature -- Therapeutic peptides in skin and hair disorders. . |
요약 | This book compiles updated research about the implications of therapeutic proteins in various human diseases. The initial chapters of the book provide basic information on the therapeutic proteins and discuss techniques for their formulation, production, and analytic approaches for their characterization. The subsequent chapters shed light on therapies based on therapeutic proteins against metabolic disorders, neurological disorders, cancer, autoimmune disorders, and infectious diseases. Importantly, it presents the factors influencing the immunogenicity of therapeutic proteins, including, genetic factors, disease type, and origin of therapeutic protein, dose frequency, administration route, and treatment duration. The book also reviews the strategies for reducing immunogenicity associated with therapeutic proteins, including PEGylation, site specific mutagenesis, exon shuffling, and humanizing of monoclonal antibodies. Further, it presents strategies for improving the typical drawback associated with protein therapeutics including instability and limited penetration through biological barriers. This book covers various computational methods that are commonly used for designing therapeutic proteins and in silico method for predicting and improving in vivo efficacy of the therapeutic molecules. Lastly, the book highlights the recent advances in developing nanosized delivery systems to improve safety and efficacy of protein therapeutics. This book caters to students and researchers of medicinal chemistry, pharmaceutical sciences and therapeutics. It is also useful to clinicians working with therapeutic proteins. |
일반주제명 | Therapeutics. Diseases. Pharmacology. Clinical biochemistry. Proteins . Therapeutics. Diseases. Pharmacology. Medical Biochemistry. Protein Biochemistry. |
바로가기 | URL |